Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Trujillo

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Virology|December 28, 2012
Transgenic CCL2 expression in the central nervous system results in a dysregulated immune response and enhanced lethality after coronavirus infectionJonathan A Trujillo, Erica L Fleming, Stanley Perlman
Cancer Immunology Research|September 6, 2018
T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy SelectionJonathan A Trujillo, Randy F Sweis, Riyue Bao, et al.
Biopreservation and Biobanking|June 30, 2022
Insights from a Rapidly Implemented COVID-19 Biobank Using Electronic Consent and Informatics ToolsEmily F Higgs, Blake A Flood, Athalia R Pyzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2014
Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopesJonathan A Trujillo, Stephanie Gras, Kelly-Anne Twist, et al.
Journal for Immunotherapy of Cancer|November 10, 2019
Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanomaJonathan A Trujillo, Jason J Luke, Yuanyuan Zha, et al.
Blood|April 21, 2021
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphomaJonathan A Trujillo, James Godfrey, Yifei Hu, et al.
The Journal of Biological Chemistry|August 20, 2014
The cellular redox environment alters antigen presentationJonathan A Trujillo, Nathan P Croft, Nadine L Dudek, et al.
Frontiers in Oncology|August 2, 2021
Doublecortin-Like Kinase 1 (DCLK1) Is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell CarcinomaEsther C Broner, Jonathan A Trujillo, Michael Korzinkin, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19Garth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.
Clinical Pharmacology and Therapeutics|November 19, 2020
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 PneumoniaGarth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Virology|December 28, 2012
Transgenic CCL2 expression in the central nervous system results in a dysregulated immune response and enhanced lethality after coronavirus infectionJonathan A Trujillo, Erica L Fleming, Stanley Perlman
Cancer Immunology Research|September 6, 2018
T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy SelectionJonathan A Trujillo, Randy F Sweis, Riyue Bao, et al.
Biopreservation and Biobanking|June 30, 2022
Insights from a Rapidly Implemented COVID-19 Biobank Using Electronic Consent and Informatics ToolsEmily F Higgs, Blake A Flood, Athalia R Pyzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2014
Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopesJonathan A Trujillo, Stephanie Gras, Kelly-Anne Twist, et al.
Journal for Immunotherapy of Cancer|November 10, 2019
Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanomaJonathan A Trujillo, Jason J Luke, Yuanyuan Zha, et al.
Blood|April 21, 2021
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphomaJonathan A Trujillo, James Godfrey, Yifei Hu, et al.
The Journal of Biological Chemistry|August 20, 2014
The cellular redox environment alters antigen presentationJonathan A Trujillo, Nathan P Croft, Nadine L Dudek, et al.
Frontiers in Oncology|August 2, 2021
Doublecortin-Like Kinase 1 (DCLK1) Is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell CarcinomaEsther C Broner, Jonathan A Trujillo, Michael Korzinkin, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19Garth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.
Clinical Pharmacology and Therapeutics|November 19, 2020
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 PneumoniaGarth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.
Pageof 2